EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab

Beatrice Preti iD, Laila Schenkel iD, Matthew Cecchini, Tommaso Romagnoli, Michael Susmoy Sanatani, Karissa French, Patrick Colquhoun, Mark David Vincent

Current Oncology · 2023

DOI: 10.3390/curroncol30100653 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Current Oncology, 2023. Verfasst von Beatrice Preti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Oncology, Western University, London, ON N6A 3K7, Canada. Hauptthemen laut MEDLINE: Mosaicism, Neoadjuvant Therapy, Colonic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research received no external funding..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present a fascinating case of a 57-year-old male with a novel mutation in MLH1 (MLH1:c.1288G > T, p.(Glu430*)), who presented with two synchronous colonic tumours, initially deemed unresectable, and experienced a complete pathological response on neoadjuvant pembrolizumab. Extensive genetic testing revealed post-zygotic mosaicism from the novel mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MosaicismNeoadjuvant TherapyColonic NeoplasmsHumansMaleMiddle AgedMicrosatellite InstabilityMutationMutL Protein Homolog 1Antibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

MLH1MSI-Hcolon cancerdMMRimmunotherapy

Substanzen

MutL Protein Homolog 1MLH1 protein, humanpembrolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Oncology, Western University, London, ON N6A 3K7, Canada.
  • Division of Molecular Diagnostics, Western University, London, ON N6A 3K7, Canada.
  • Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
  • Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Department of Surgery, Western University, London, ON N6A 3K7, Canada.

ORCID-Profile: Beatrice Preti, Laila Schenkel

Förderung

  • This research received no external funding.

Zitieren

APA

Preti, B., Schenkel, L., Cecchini, M., Romagnoli, T., Sanatani, M. S., French, K., Colquhoun, P., & Vincent, M. D. (2023). Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab. Current Oncology. https://doi.org/10.3390/curroncol30100653

Vancouver

Preti B, Schenkel L, Cecchini M, Romagnoli T, Sanatani MS, French K, et al. Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab. Current Oncology. 2023. doi:10.3390/curroncol30100653

BibTeX
@article{Preti2023,
  author = {Preti, Beatrice and Schenkel, Laila and Cecchini, Matthew and Romagnoli, Tommaso and Sanatani, Michael Susmoy and French, Karissa and Colquhoun, Patrick and Vincent, Mark David},
  title = {Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30100653}
}
Kostenlos starten →